Astera Labs (NASDAQ:ALAB) Trading 9.6% Higher – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shares traded up 9.6% on Wednesday . The stock traded as high as $224.76 and last traded at $224.09. 6,368,550 shares traded hands during trading, an increase of 18% from the average session volume of 5,381,206 shares. The stock had previously closed at $204.42.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Northland Securities sharply raised its earnings outlook for Astera Labs (ALAB) across multiple periods, including FY2026, FY2027, and several quarterly estimates, signaling stronger expected profitability ahead.
• Positive Sentiment: Analyst sentiment is also improving elsewhere, with another report lifting ALAB’s price target to $246.06, reinforcing the view that Wall Street sees more upside in the stock. Astera Labs price target increased by 20.85% to 246.06
• Positive Sentiment: Zacks highlighted strong UALink 2.0 momentum and Scorpio switch expansion, saying these products are helping drive Astera Labs’ AI infrastructure growth and could support additional upside as deployments build into 2027. ALAB Benefits From Strong UALink Growth: More Upside Ahead?

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Loop Capital assumed coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Weiss Ratings raised shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Finally, Needham & Company LLC lifted their target price on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $229.65.

Astera Labs Stock Performance

The business’s 50-day moving average price is $153.02 and its 200-day moving average price is $155.87. The stock has a market cap of $39.88 billion, a P/E ratio of 157.22, a P/E/G ratio of 2.97 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the firm posted $0.33 EPS. The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Activity

In other news, COO Sanjay Gajendra sold 230,639 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $198.22, for a total transaction of $45,717,262.58. Following the completion of the sale, the chief operating officer owned 664,361 shares of the company’s stock, valued at $131,689,637.42. The trade was a 25.77% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $200.03, for a total transaction of $701,105.15. Following the transaction, the director owned 63,639 shares in the company, valued at approximately $12,729,709.17. This trade represents a 5.22% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,497,338 shares of company stock valued at $236,827,957 in the last 90 days. Company insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Lido Advisors LLC lifted its stake in shares of Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares in the last quarter. Perigon Wealth Management LLC lifted its stake in shares of Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after buying an additional 73 shares in the last quarter. Clearstead Advisors LLC lifted its stake in shares of Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after buying an additional 76 shares in the last quarter. Sound Income Strategies LLC lifted its stake in shares of Astera Labs by 9.2% during the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after buying an additional 76 shares in the last quarter. Finally, Venturi Wealth Management LLC lifted its stake in shares of Astera Labs by 2.6% during the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after buying an additional 84 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.